Dimethyl diacetyl cystinate (DACDM) is a potent NF-kappaB inhibitor. Dimethyl diacetyl cystinate shifts the intracellular redox balance toward the oxidized state by increasing intracellular oxidized glutathione (GSSG) content, competitively blocking the binding of activated NF-kappaB to DNA, thereby inhibiting the production of inflammatory factors such as IL-1kappa. Dimethyl diacetyl cystinate is promising for research of UVB-induced skin inflammation and related oxidative stress diseases[1].
Molekulargewicht:
352.43
CAS Nummer:
[32381-28-5]
Formel:
C12H20N2O6S2
Target-Kategorie:
Interleukin Related,NF-kappaB
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
